CarlLenarskyMD

Pediatric Hematology & Oncology • Dallas, TX

Physician

Join to view full profile

Dr. Lenarsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lenarsky's full profile

Already have an account?

Office
7777 Forest Ln Bldg D
Suite 400
Dallas, TX 75230
Phone+1 972-566-6647

Fax+1 972-566-6496
Is this information wrong?

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Hematology/Oncology, 1980 - 1982
Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterFellowship, Pediatric Hematology/Oncology, 1979 - 1980
Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterResidency, Pediatrics, 1977 - 1979
New York Medical CollegeClass of 1977

Certifications & Licensure

CA State Medical License 1980 - 2025
TX State Medical License 1996 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Super Doctor SuperDoctors.com

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma Start of enrollment: 2004 Mar 15
Completed
Phase 3
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Start of enrollment: 2004 Sep 04
Completed
Phase 3
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors Start of enrollment: 2004 Mar 22
Recruiting
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma Start of enrollment: 2005 Nov 14
Completed
Phase 3
Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission Start of enrollment: 2005 May 30
Completed
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Start of enrollment: 2006 Jun 01
Completed
Phase 2
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma Start of enrollment: 2007 Aug 06
Active, not recruiting
Phase 3
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor Start of enrollment: 2006 Oct 30
Active, not recruiting
Phase 3
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Start of enrollment: 2006 Dec 26
Completed
Phase 3
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes Start of enrollment: 2007 Mar 01
Completed
Phase 3
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor Start of enrollment: 2007 Feb 26
Active, not recruiting
Phase 3
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia Start of enrollment: 2007 Mar 01
Completed
Phase 3
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission Start of enrollment: 2007 Mar 01
Completed
Phase 3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Start of enrollment: 2007 Jan 22
Active, not recruiting
Phase 3
Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma Start of enrollment: 2008 Feb 04
Active, not recruiting
Phase 3
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2008 Jan 15
Active, not recruiting
Phase 3
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 May 19
Recruiting
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2008 Sep 15
Recruiting
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2009 Jan 01
Completed
Phase 2
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Start of enrollment: 2006 Sep 25
Completed
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma Start of enrollment: 2006 Oct 23
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
Completed
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Start of enrollment: 2009 Jul 13
Active, not recruiting
Phase 3
Study of Blood Samples From Newborns With Down Syndrome Start of enrollment: 2009 Feb 23
Completed
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma Start of enrollment: 2005 May 30
Completed
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma Start of enrollment: 2010 Jan 01
Completed
Phase 2
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia Start of enrollment: 2011 Feb 01
Completed
Phase 2
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma Start of enrollment: 2010 Oct 01
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma Start of enrollment: 2011 Sep 01
Completed
Phase 2
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Start of enrollment: 2013 Mar 21
Completed
Phase 3
Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment Start of enrollment: 2014 Mar 05
Recruiting
Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia Start of enrollment: 2013 Jun 24
Completed
Phase 2
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Join now to see all

Publications & Presentations

PubMed

14 citations
Three-year Follow up of GMCSF/bi-shRNA(furin) DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma.
Maurizio Ghisoli, Minal Barve, Robert Mennel, Carl Lenarsky, Staci Horvath, Gladice Wallraven, Beena O Pappen, Sam Whiting, Donald Rao, Neil Senzer, John Nemunaitis> ;Molecular Therapy. 2016 Aug 1
38 citations
Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma
Maurizio Ghisoli, Minal A. Barve, Reva Schneider, Robert G. Mennel, Carl Lenarsky, Gladice Wallraven, Beena O. Pappen, John LaNoue, Padmasini Kumar, Derek Nemunaitis, ...> ;Molecular Therapy. 2015 Jun 1
9 citations
Pre- and post-natal treatment of hemophagocytic lymphohistiocytosis.
Ami J. Shah, Neena Kapoor, Robert Cooper, Carl Lenarsky, Hisham Abdel-Azim, Shi Qi Wu, Kathy Wilson, Kenneth I. Weinberg, Robertson Parkman, Donald B. Kohn> ;Pediatric Blood & Cancer. 2009 Jan 1
25 citations
Translocation (4;19)(q35;q13.1)-associated primitive round cell sarcoma: report of a case and review of the literature.
Dinesh Rakheja, Stanton C. Goldman, Kathleen S. Wilson, Carl Lenarsky, Joel Weinthal, Roger A. Schultz> ;Pediatric and Developmental Pathology. 2006 Jan 1
20 citations
Busulfan and cyclophosphamide as a conditioning regimen for pediatric acute lymphoblastic leukemia patients undergoing bone marrow transplantation.
Ami J. Shah, Carl Lenarsky, Neena Kapoor, Donald B. Kohn, Robertson Parkman, Karen Epport, Kathy Wilson, Ken I. Weinberg> ;Journal of Pediatric Hematology/oncology. 2004 Feb 1
14 citations
Second hematopoietic stem cell transplantation in pediatric patients: Overall survival and long-term follow-up
Ami J. Shah, Neena Kapoor, Kenneth I. Weinberg, Donald B. Kohn, Carl Lenarsky, Francine R. Kaufman, Karen Epport, Kathy Wilson, Robertson Parkman> ;Biology of Blood and Marrow Transplantation. 2002 Apr 1
9 citations
Feasibility study of IL-11 and granulocyte colony-stimulating factor after myelosuppressive chemotherapy to mobilize peripheral blood stem cells from heavily pretreate...
Stanton Goldman, F. Bracho, Virginia Davenport, Rebecca Slack, Areman Em, Violet Shen, Carl Lenarsky, Joel Weinthal, Rosemarie Hughes, Mitchell S. Cairo> ;Journal of Pediatric Hematology/oncology. 2001 Jun 1
2 citations
Amendment to Clinical Research Project Project 90-C-195
Cindy Dunbar, Lauren A. Chang, Craig A. Mullen, William J. Ramsey, Charles S. Carter, Donald B. Kohn, Robertson Parkman, Carl Lenarsky, Kenneth I. Weinberg, Diane W. W...> ;Human Gene Therapy. 1999 Feb 10
245 citations
Hurler Syndrome: II. Outcome of HLA-Genotypically Identical Sibling and HLA-Haploidentical Related Donor Bone Marrow Transplantation in Fifty-Four Children
Charles Peters, Elsa Shapiro, James A. Anderson, P. Jean Henslee-Downey, Martin R. Klemperer, Morton J. Cowan, E. Fred Saunders, Pedro A. deAlarcon, Clare J. Twist, Ja...> ;Blood. 1998 Apr 1
239 citations
Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome.
Charles Peters, Michael Balthazor, Elsa Shapiro, Roberta King, Craig Kollman, Janet D. Hegland, Jean Henslee-Downey, Michael E. Trigg, Morton J. Cowan, Jean E. Sanders...> ;Blood. 1996 Jun 1
116 citations
The effect of thymic function on immunocompetence following bone marrow transplantation.
Kenneth I. Weinberg, Geralyn Annett, Kashyap A, Carl Lenarsky, Forman Sj, Robertson Parkman> ;Biology of Blood and Marrow Transplantation. 1995 Nov 1
452 citations
Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency.
Donald B. Kohn, Kenneth I. Weinberg, Jan A. Nolta, L N Heiss, Carl Lenarsky, Crooks Gm, M E Hanley, G Annett, J. Brooks, A el-Khoureiy> ;Nature Medicine. 1995 Oct 1
9 citations
Immune recovery after bone marrow transplantation.
Carl Lenarsky> ;Current Opinion in Hematology. 1995 Nov 1
5 citations
Bone marrow transplantation for metabolic diseases.
Robertson Parkman, Crooks Gm, Donald B. Kohn, Carl Lenarsky, Kenneth I. Weinberg> ;Cancer Treatment and Research. 1995 Jan 1
16 citations
Unrelated donor BMT for Wiskott-Aldrich syndrome.
Carl Lenarsky, Kenneth I. Weinberg, Donald B. Kohn, Robertson Parkman> ;Bone Marrow Transplantation. 1993 Aug 1
7 citations
Granulocyte recovery in pediatric marrow transplant recipients treated with ganciclovir for cytomegalovirus infection.
William Roberts, Kenneth I. Weinberg, Donald B. Kohn, Leonard S. Sender, Robertson Parkman, Carl Lenarsky> ;The American Journal of Pediatric Hematology/oncology. 1993 Aug 1
39 citations
T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase.
Kenneth I. Weinberg, Michael S. Hershfield, John F. Bastian, Donald B. Kohn, Leonard S. Sender, Robertson Parkman, Carl Lenarsky> ;The Journal of Clinical Investigation. 1993 Aug 1
18 citations
Mechanisms in immune recovery after bone marrow transplantation. Management of posttransplant immune deficiency.
Carl Lenarsky> ;The American Journal of Pediatric Hematology/oncology. 1993 Feb 1
72 citations
13‐cis‐retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: Report from the childrens cance...
Jerry Z. Finklestein, Mark Krailo, Carl Lenarsky, Stephen Ladisch, Geoffrey K. Blair, C. Patrick Reynolds, Anneliese L. Sitarz, G. Denman Hammond> ;Medical and Pediatric Oncology. 1992 Jan 1
46 citations
Desmoplastic Small Cell Tumors of the Peritoneum Coexpressing Mesenchymal and Epithelial Markers
Lester J. Layfield, Carl Lenarsky> ;American Journal of Clinical Pathology. 1991 Oct 1
58 citations
Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome.
M F Ozkaynak, Kenneth I. Weinberg, Donald B. Kohn, Leonard S. Sender, Robertson Parkman, Carl Lenarsky> ;Bone Marrow Transplantation. 1991 Jun 1
13 citations
Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for children with acute non-lymphoblastic leukemia in second remission.
Carl Lenarsky, Kenneth I. Weinberg, J. Petersen, Jan A. Nolta, J. Brooks, G Annett, Donald B. Kohn, Robertson Parkman> ;Bone Marrow Transplantation. 1990 Dec 1
23 citations
Bone marrow transplantation for the treatment of immune deficiency states.
Carl Lenarsky, Robertson Parkman> ;Bone Marrow Transplantation. 1990 Dec 1
11 citations
Bone marrow transplantation for genetic diseases.
Carl Lenarsky, Donald B. Kohn, Kenneth I. Weinberg, Robertson Parkman> ;Hematology/oncology Clinics of North America. 1990 Jun 1
12 citations
Mycobacterium avium-intracellulare infections after allogeneic bone marrow transplantation in children.
M F Ozkaynak, Carl Lenarsky, Donald B. Kohn, Kenneth I. Weinberg, Robertson Parkman> ;The American Journal of Pediatric Hematology/oncology. 1990 Jan 1
Join now to see all

Hospital Affiliations

Medical City PlanoPlano, Texas
Texas Health Presbyterian Hospital DallasDallas, Texas
Texas Health Presbyterian Hospital PlanoPlano, Texas
Medical City DallasDallas, Texas

CarlLenarskyMD

Dr. Lenarsky is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.